Oncology & Cancer

Margin-positive surgery still beneficial in pancreatic cancer

(HealthDay)—For patients with stage II pancreatic cancer, attempted surgery with margin-positive resection may offer survival benefit over chemotherapy alone, according to a study published online March 26 in the Journal ...

Oncology & Cancer

Bladder cancer—when to use chemotherapy

In patients with bladder cancer, chemotherapy effectiveness is partially determined by the body's immune system response to the malignancy. This is the conclusion of research conducted by a team of scientists from Charité ...

Oncology & Cancer

Few high-grade soft tissue sarcoma patients receive chemo

(HealthDay)—The rates of adults with high-grade soft tissue sarcoma (STS) who receive chemotherapy may be lower than expected, indicating a need for more aggressive systemic treatments, according to a study published in ...

Oncology & Cancer

Study shows genetic effects of pre-surgical chemo in breast cancer

Results from one of the first studies to determine the effects of pre-surgical, or neoadjuvant, chemotherapy on the breast cancer genome offer up two key insights. One is a before treatment finding that can help predict which ...

Oncology & Cancer

Less chemotherapy may have more benefit in rectal cancer

Chemotherapy used to shrink a tumor before surgery, called neoadjuvant chemotherapy, is becoming more common in many cancers, including stage II and III rectal cancer. However, the chemotherapy regimens FOLFOX and CapeOx ...

page 1 from 6